Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imeglimin add-on to sitagliptin in inadequately controlled type 2 diabetes
2010-023915-33Phase 2Completed
- Sponsor
- Poxel SA
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Imeglimin add-on to sitagliptin with Placebo add-on to sitagliptin (2 arms). Primary endpoint: Change in HbA1c from baseline to Week 12. Started Mar 2011; status: completed.
02
Drugs
imeglimin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2010-023915-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023915-33.